Pr Voranigo 40 mg contains vorasidenib, an anti-neoplastic medicine used under specialist medical supervision for eligible patients with certain IDH-mutant gliomas, a type of brain tumor.
The appropriate dose and duration of treatment depend on the patient's medical condition, tumor characteristics, other medicines, and overall health. Do not start, stop, or change the dose without medical advice.
For product availability, genuine sourcing, and medical guidance, consult a qualified healthcare professional or authorized medicine supplier.
Trade Partners
Franchise
Download PDF